In Trading, Results Matter.
Our Top 10 exits in last 5 trading days.

Applied Genetic Technologies Corp.. Trade Record

NASDAQ:AGTC Applied Genetic Technologies Corp. stock gains 7.64% Exit Jan 16, 2018 a Trade Record by priceseries

Trade Chart
Trade Chart AGTC Jan 2, 2018, priceSeries
About Applied Genetic Technologies Corp.

Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops genetic therapies to treat patients with inherited diseases. Its lead products consist of four ophthalmology development programs across three targets, including X linked retinoschisis (XLRS) that is in a Phase I/II clinical trials for the treatment of an inherited retinal disease; X-linked retinitis pigmentosa (XLRP), which is enrolling patients in a Phase I/II clinical trials; and achromatopsia (ACHM) that is enrolling patients in a Phase I/II clinical trials. Applied Genetic Technologies Corporation has collaboration agreements with Biogen MA, Inc.; 4D Molecular Therapeutics; and Synpromics Limited. The company was founded in 1999 and is headquartered in Alachua, Florida.

Trade Information
Trade Type
Entry Date
Jan 2, 2018
Entry Price
Sell Date
Jan 16, 2018
Sell Price
Net Gain
Hold Time
9 Trading Days